Shaobin Yu
Impact in
- Toxicology top 10%
Papers in
-
- Lung Cancer Diagnosis and Treatment 7
- Gastric Cancer Management and Outcomes 2
- Metastasis and carcinoma case studies 2
- Sarcoma Diagnosis and Treatment 1
- Surgery 10
- Esophageal Cancer Research and Treatment 8
- Co-authors
- Xue Bai (1 shared paper)Qiang Shen (1 shared paper)Ziqiang Han (2 shared papers)David P. Eisenman (1 shared paper)Ping Fu (3 shared papers)Lin Liu (1 shared paper)Xiaoxi Zeng (4 shared papers)Ling Zhang (2 shared papers)
- Journals
- Translational Lung Cancer Research (3 papers)BMC Nephrology (2 papers)Annals of Palliative Medicine (2 papers)Translational Psychiatry (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Shaobin Yu
35 papers receiving 536 citations
Peers
Comparison fields: 5 of 126
- Toxicology 20
- Biological Psychiatry 11
- Nephrology 30
- Cellular and Molecular Neuroscience 57
- Emergency Medical Services 18
Countries citing papers authored by Shaobin Yu
This map shows the geographic impact of Shaobin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaobin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaobin Yu more than expected).
Fields of papers citing papers by Shaobin Yu
This network shows the impact of papers produced by Shaobin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaobin Yu. The network helps show where Shaobin Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shaobin Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 146 | |
| 2 | 2015 | 63 | |
| 3 | 2022 | 50 | |
| 4 | 2021 | 47 | |
| 5 | 2021 | 43 | |
| 6 | 2020 | 28 | |
| 7 | 2020 | 26 | |
| 8 | 2017 | 20 | |
| 9 | 2021 | 14 | |
| 10 | 2020 | 12 | |
| 11 | 2016 | 11 | |
| 12 | 2020 | 8 | |
| 13 | 2021 | 8 | |
| 14 | 2025 | 7 | |
| 15 | 2019 | 7 | |
| 16 | 2024 | 6 | |
| 17 | 2021 | 6 | |
| 18 | 2021 | 5 | |
| 19 | 2020 | 4 | |
| 20 | 2023 | 4 |
About Shaobin Yu
Shaobin Yu is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Epidemiology, Nephrology and Cardiology and Cardiovascular Medicine, having authored 40 papers that have together received 548 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (8 papers), Lung Cancer Diagnosis and Treatment (7 papers), Dialysis and Renal Disease Management (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Gastric Cancer Management and Outcomes (2 papers), Metastasis and carcinoma case studies (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and Allergic Rhinitis and Sensitization (1 paper). The work is most often cited by research in Toxicology (20 citations), Biological Psychiatry (11 citations), Nephrology (30 citations), Cellular and Molecular Neuroscience (57 citations) and Emergency Medical Services (18 citations). Shaobin Yu has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Xue Bai, Qiang Shen, Ziqiang Han, David P. Eisenman, Ping Fu, Lin Liu, Xiaoxi Zeng, Ling Zhang, Yuliang Zhao and Jiaojiao Zhou. Their work appears in journals such as Translational Lung Cancer Research, BMC Nephrology, Annals of Palliative Medicine, Translational Psychiatry and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.